Characterization and Functional Analysis of Tumor-Derived Microparticles

Jingwei Ma1, Ke Tang2, Huafeng Zhang3

  • 1Department of Immunology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

Current Protocols
|June 8, 2021
PubMed

Insights

Tumor cell-derived microparticles (T-MPs) are key in intercellular communication and can be isolated and characterized. These T-MPs hold potential for tumor immunotherapies and vaccines due to their ability to modulate immune responses.

Area of Science:

  • Cell Biology
  • Immunology
  • Biotechnology

Background:

  • Microparticles (MPs) are cell-derived vesicles crucial for intercellular communication.
  • Tumor cell-derived microparticles (T-MPs) are prevalent in tumor microenvironments (TMEs) and contain bioactive molecules.
  • T-MPs influence immune cell function and responses, and can be utilized as drug delivery vehicles.

Purpose of the Study:

  • To provide protocols for isolating, characterizing, and validating T-MPs.
  • To outline methods for analyzing T-MP interactions with target cells.
  • To explore the potential of T-MPs in tumor immunotherapy and vaccine development.

Main Methods:

  • Multi-step centrifugation for T-MP isolation from cultured tumor cells.
  • Standardized protocols for characterization and validation of isolated MPs.
  • Functional assays to analyze T-MP uptake by various cell types.

Main Results:

  • Established protocols for obtaining and validating T-MPs.
  • Demonstrated methods for assessing T-MP interactions with target cells.
  • Provided a framework for utilizing T-MPs in therapeutic applications.

Conclusions:

  • T-MPs are versatile biomaterials with significant potential in cancer immunotherapy and vaccine design.
  • The described protocols facilitate research into T-MP biology and therapeutic applications.
  • T-MPs can be leveraged to remodel TMEs and enhance anti-tumor immunity.